ENDS Adults Who Smoke: Difference between revisions
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
===[https://www.ahajournals.org/doi/10.1161/JAHA.120.019324 Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for Atherosclerosis]=== | ===[https://www.ahajournals.org/doi/10.1161/JAHA.120.019324 Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for Atherosclerosis]=== | ||
===[https://academic.oup.com/aje/article/187/11/2397/5046037 Can E-Cigarettes and Pharmaceutical Aids Increase Smoking Cessation and Reduce Cigarette Consumption? Findings From a Nationally Representative Cohort of American Smokers]=== | |||
=Dual Use= | =Dual Use= | ||
| Line 264: | Line 266: | ||
=Quitting Smoking: E-cigarette vs. NRT OR E-cigarette with NRT= | =Quitting Smoking: E-cigarette vs. NRT OR E-cigarette with NRT= | ||
===2021: [https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00475-7 Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids]=== | |||
*One third of the total sample was biochemically verified smoking abstinent 7 months after quit date, with e-cigarette users (40%) having significantly higher chances to be smoking abstinent than NRT users (23%). | |||
*[https://harmreductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-021-00475-7.pdf PDF Version] | |||
*Citation: Adriaens, K., Belmans, E., Van Gucht, D. et al. Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids. Harm Reduct J 18, 28 (2021). https://doi.org/10.1186/s12954-021-00475-7 | |||
*Acknowledgement: This research received no external funding. EB is supported by a PhD-fellowship of the Research Foundation – Flanders (FWO-Vlaanderen; 1177820N). | |||
| Line 349: | Line 358: | ||
===2011: Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series=== | ===2011: Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series=== | ||
The most important message from this case series is that these smokers, with a documented history of recurring relapses, were able to quit smoking and to remain abstinent for at least six months after taking up an electronic cigarette. | The most important message from this case series is that these smokers, with a documented history of recurring relapses, were able to quit smoking and to remain abstinent for at least six months after taking up an electronic cigarette. | ||
=Quitting Smoking / Preventing Relapse (No comparison to other methods)= | =Quitting Smoking / Preventing Relapse (No comparison to other methods)= | ||